Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Briacell Therapeutics Corp. (BCTX) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Briacell Therapeutics Corp.. Table 2 shows the detailed insider transactions. This company's CIK number is 1610820.
Total stock buying since 2022: $2,502,420.
Total stock sales since 2022: $0.
Total stock option exercises since 2022: $0.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2024 | 902,935 | $2,000,001 | 0 | $0 | 0 | $0 |
2022 | 106,000 | $502,419 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2024-05 | 902,935 | $2,000,001 | 0 | $0 | 0 | $0 |
2022-12 | 106,000 | $502,419 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-05-14 | Lustig Marc | Buy | 902,935 | 2.21 | 2,000,001 |
2022-12-28 | Bondarenko Jamieson (Chairman) | Buy | 56,000 | 4.58 | 256,480 |
2022-12-20 | Bondarenko Jamieson | Buy | 22,000 | 5.35 | 117,699 |
Insider trading activities including stock purchases, stock sales, and option exercises of BCTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Briacell Therapeutics Corp. (symbol BCTX, CIK number 1610820) see the Securities and Exchange Commission (SEC) website.